HDSN vs. ACHV
HDSN (Hudson Technologies, Inc.) and ACHV (Achieve Life Sciences, Inc.) are both stocks. HDSN operates in Specialty Chemicals (Basic Materials), while ACHV operates in Biotechnology (Healthcare). Over the past 10 years, HDSN returned 5.11%/yr vs -45.09%/yr for ACHV. At a 0.08 correlation, their price movements are largely independent.
Performance
HDSN vs. ACHV - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, HDSN achieves a -15.91% return, which is significantly lower than ACHV's 2.62% return. Over the past 10 years, HDSN has outperformed ACHV with an annualized return of 5.11%, while ACHV has yielded a comparatively lower -45.09% annualized return.
HDSN
- 1D
- -2.04%
- 1M
- 13.83%
- YTD
- -15.91%
- 6M
- -17.00%
- 1Y
- -25.58%
- 3Y*
- -14.45%
- 5Y*
- 12.47%
- 10Y*
- 5.11%
ACHV
- 1D
- 5.15%
- 1M
- 8.74%
- YTD
- 2.62%
- 6M
- 14.35%
- 1Y
- 52.24%
- 3Y*
- -4.79%
- 5Y*
- -9.48%
- 10Y*
- -45.09%
HDSN vs. ACHV - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
HDSN Hudson Technologies, Inc. | -15.91% | 22.76% | -58.64% | 33.30% | 127.93% | 307.34% | 11.51% | 9.83% | -85.34% | -24.22% |
ACHV Achieve Life Sciences, Inc. | 2.62% | 41.19% | -14.56% | 68.16% | -68.51% | -3.95% | -23.58% | -56.20% | -90.99% | -75.57% |
Correlation
The correlation between HDSN and ACHV is 0.16, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.16 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.16 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.17 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.11 |
Correlation (All Time) Calculated using the full available price history since Oct 13, 1995 | 0.08 |
Fundamentals
HDSN:
$245.24M
ACHV:
$272.25M
HDSN:
$0.32
ACHV:
-$1.08
HDSN:
1.03
ACHV:
25.50
HDSN:
$251.42M
ACHV:
$0.00
HDSN:
$61.88M
ACHV:
-$111.00K
HDSN:
$22.33M
ACHV:
-$41.34M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
HDSN vs. ACHV — Risk / Return Rank
HDSN
ACHV
HDSN vs. ACHV - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Hudson Technologies, Inc. (HDSN) and Achieve Life Sciences, Inc. (ACHV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| HDSN | ACHV | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.07 | ||
| Sortino ratioReturn per unit of downside risk | -1.90 | ||
| Omega ratioGain probability vs. loss probability | 0.93 | 1.21 | -0.28 |
| Calmar ratioReturn relative to maximum drawdown | -0.48 | 0.96 | -1.44 |
| Martin ratioReturn relative to average drawdown | -0.84 | 2.15 | -2.99 |
Loading charts...
Drawdowns
HDSN vs. ACHV - Drawdown Comparison
The maximum HDSN drawdown since its inception was -98.81%, roughly equal to the maximum ACHV drawdown of -100.00%. Use the drawdown chart below to compare losses from any high point for HDSN and ACHV.
Loading charts...
Drawdown Indicators
| HDSN | ACHV | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -98.81% | -100.00% | +1.19% |
Max Drawdown (1Y)Largest decline over 1 year | -53.64% | -54.55% | +0.91% |
Max Drawdown (3Y)Largest decline over 3 years | -67.65% | -66.58% | -1.07% |
Max Drawdown (5Y)Largest decline over 5 years | -67.65% | -80.11% | +12.46% |
Max Drawdown (10Y)Largest decline over 10 years | -96.72% | -99.91% | +3.19% |
Current DrawdownCurrent decline from peak | -77.96% | -99.99% | +22.03% |
Average DrawdownAverage peak-to-trough decline | -83.34% | -83.85% | +0.51% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 30.64% | 24.34% | +6.30% |
Volatility
HDSN vs. ACHV - Volatility Comparison
The current volatility for Hudson Technologies, Inc. (HDSN) is 11.94%, while Achieve Life Sciences, Inc. (ACHV) has a volatility of 21.60%. This indicates that HDSN experiences smaller price fluctuations and is considered to be less risky than ACHV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| HDSN | ACHV | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 11.94% | 21.60% | -9.66% |
Volatility (6M)Calculated over the trailing 6-month period | 33.87% | 68.04% | -34.17% |
Volatility (1Y)Calculated over the trailing 1-year period | 47.13% | 100.86% | -53.73% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 57.45% | 74.40% | -16.95% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 78.65% | 91.51% | -12.86% |
Dividends
HDSN vs. ACHV - Dividend Comparison
Neither HDSN nor ACHV has paid dividends to shareholders.
Financials
HDSN vs. ACHV - Financials Comparison
This section allows you to compare key financial metrics between Hudson Technologies, Inc. and Achieve Life Sciences, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
HDSN and ACHV have a correlation of 0.16, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ACHV has higher volatility (21.60%) compared to HDSN (11.94%). In terms of maximum drawdown, HDSN dropped -98.81% vs ACHV's -100.00%.
ACHV currently has the higher Sharpe Ratio (0.52 vs -0.55), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for HDSN and ACHV
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer